BL Pharmtech Agrees to Sell 13.96% Stake in Kwangdong Healthbio
BL Pharmtech agreed to sell a 13.96% stake in Kwangdong Healthbio.
Related stories
Adani Ports selected to buy 100% stake in EVOS B.V.
M impact | MNA | Nov 05, 2026, 09:40 AM UTC
Sappi, UPM Offer Remedies to Seek EU Approval for Paper JV
Sappi and UPM have offered remedies in a bid to secure EU antitrust approval for their paper joint venture.
L impact | MNA | Nov 05, 2026, 09:15 AM UTC
AstraZeneca Makes About $10 Billion Offer for Rhythm Pharmaceuticals
AstraZeneca has made an offer of about $10 billion for Rhythm Pharmaceuticals, MT Newswires reports.
M impact | MNA | Nov 05, 2026, 09:07 AM UTC
Air France-KLM Hopes to Complete SAS Deal by Q1 2027
Air France-KLM’s CEO said the company hopes to complete its deal for SAS by Q1 2027.
L impact | MNA | Nov 05, 2026, 09:04 AM UTC
Total Graphite announces acquisition and £0.41m CLN fundraise
M impact | MNA | Nov 05, 2026, 09:00 AM UTC
China Blocks SoftBank’s $5.4 Billion Acquisition of ABB Robotics Unit
China blocked SoftBank’s acquisition of ABB’s robotics unit, a deal valued at $5.4 billion.
M impact | MNA | Nov 05, 2026, 08:56 AM UTC